{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-069889","form_type":"8-K","ticker":"ICU","cik":"0001831868","company_name":"SeaStar Medical Holding Corp","filed_at":"2023-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.850144+00:00","generated_at":"2026-06-07T13:36:14.096421+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SeaStar Medical receives Nasdaq delisting notice for failing Market Value Rule; hearing requested","bullets":["Nasdaq notified SeaStar on Dec 12, 2023, that it failed to regain compliance with the $35M market value requirement under Listing Rule 5550(b)(2).","Company will timely request a hearing before a Nasdaq Hearing Panel, which stays any delisting action pending the hearing.","Common stock (ICU) continues trading on Nasdaq Capital Market during the hearing process.","Prior deficiency letters were disclosed in June 2023 regarding the same market value non-compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-069889","json":"https://secwatch.observer/filing/0000950170-23-069889.json","markdown":"https://secwatch.observer/filing/0000950170-23-069889.md","text":"https://secwatch.observer/filing/0000950170-23-069889.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831868/000095017023069889/0000950170-23-069889-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831868/000095017023069889/icu-20231213.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T13:36:14.096421+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"56b0498dc18593e43ffecf69ebbd7007897264cd","claim":"SeaStar Medical Holding Corp received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).","evidence_excerpt":"December 12, 2023, the Company received notification from the Staff that the Company had not regained compliance with the Market Value Rule (the “ Delisting Notice ”) or the alternative criteria. The Delisting Notice indicated that the Company’s common stock would be subject to delisting unless the Company timely requests a hearing before a Nasdaq Hearing Panel (the “ Panel ”). Accordingly, the Company intends to timely request a hearing before the Panel. The hearing request will stay any suspension or delisting action pending the hearing. Subject to the Company’s timely submission of a hearin","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000095017023069889/0000950170-23-069889-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}